Major U.S. health insurers say they will streamline controversial process for approving care
Prior authorization makes providers obtain approval from a patient's insurance company before they carry out specific services or treatments. Insurers say the process ensures patients receive medically necessary care and allows them to control costs. But patients and providers have slammed prior authorizations for, in some cases, leading to care delays or denials and physician burnout.
Dozens of plans under large insurers such as CVS Health, UnitedHealthcare, Cigna, Humana, Elevance Health and Blue Cross Blue Shield committed to a series of actions that aim to connect patients to care more quickly and reduce the administrative burden on providers, according to a release from AHIP, a trade group representing health plans.
Insurers will implement the changes across markets, including commercial coverage and certain Medicare and Medicaid plans. The group said the tweaks will benefit 257 million Americans.
The move comes months after the U.S. health insurance industry faced a torrent of public backlash following the murder of UnitedHealthcare's top executive, Brian Thompson. It builds on the work several companies have already done to simplify their prior authorization processes.
Among the efforts is establishing a common standard for submitting electronic prior authorization requests by the start of 2027. By then, at least 80% of electronic prior authorization approvals with all necessary clinical documents will be answered in real time, the release said.
That aims to streamline the process and ease the workload of doctors and hospitals, many of whom still submit requests manually on paper rather than electronically.
Individual plans will reduce the types of claims subject to prior authorization requests by 2026.
"We look forward to collaborating with payers to ensure these efforts lead to meaningful and lasting improvements in patient care," said Shawn Martin, CEO of the American Academy of Family Physicians, in the release.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
26 minutes ago
- New York Post
The first place you start to get fat isn't your stomach — it's actually this body part, and it causes a surprising side effect
Forget muffin tops and thunder thighs — weight gain starts somewhere you wouldn't expect. 'When you have too many calories and you overflow your fuel tank, the first fat that grows is inside your body, you can't see it,' Dr. William Li, a physician and food scientist, said on a recent episode of 'The Mel Robbins Podcast.' Where it starts to build up first might surprise you — and for some, it's enough to cause trouble in the bedroom. Advertisement 3 Dr. William Li appeared in an August 21 episode of 'The Mel Robbins Podcast.' TikTok/melrobbins 'When you gain weight and start to grow extra body fat, one of the first places that it grows is in the back of your tongue,' Li said. Unlike the flexible tip or the strong, muscular middle, the base of the tongue acts like a 'big fat pillow,' he explained, helping chewed food slide down into the stomach. But this area is also a prime target for visceral fat — the hidden kind that builds deep inside the body. Unlike subcutaneous fat, which sits just under the skin, this tongue fat is nearly impossible to spot with the naked eye. Advertisement Still, Li said there's a major red flag that could signal your tongue is packing on fat. 'The telltale sign is snoring or being startled when you're sleeping,' he said. As you sleep, your tongue naturally relaxes — and if it's carrying extra fat, it can start to block your airway. Advertisement 'You wake up and you snort or you start to store,' Li said. 'This is what your bed partner notices.' 3 You might spot weight gain in your stomach, thighs, or rear — but it usually starts deep beneath the surface. andriano_cz – Science backs it up. Studies have found obese people with obstructive sleep apnea — a dangerous disorder that disrupts breathing during sleep — have significantly more tongue fat than those without it, especially at the back of the tongue. That could help explain why obesity is considered a top risk factor for obstructive sleep apnea, which affects about 30 million Americans, according to the American Academy of Sleep Medicine. Advertisement And while it might sound harmless, the condition is no joke. Left untreated, it can lead to serious health consequences, including heart disease, stroke, diabetes, depression, cognitive decline and even death. @melrobbins I couldn't believe Dr. William Li told me THIS is where you start gaining fat first… It doesn't start with your belly or your thighs… It starts with your tongue. 🤔 Yes, you read that right. Dr. Li is a world-renowned physician, scientist, and bestselling author with 30+ years of research on metabolism and health that has impacted millions of people. This episode of The Mel Robbins Podcast will completely change the way you think about weight, metabolism, and your health. Dropping Thursday, August 21st! 🎧 'Do THIS to Boost Your Metabolism, Lose Fat, & Feel Better Now With Dr. William Li.' #melrobbins #melrobbinspodcast #weightgain #fatloss ♬ original sound – Mel Robbins But there's hope. In a 2020 study, researchers used MRI scans to examine how weight loss affected the airways of 67 obese patients who dropped just 10% of their body weight through diet or surgery. Their sleep apnea scores improved by 31%, and the images showed that their slimmer tongues were the primary reason. 'In fact, the more tongue fat you lost, the more your apnea improved,' Richard Schwab, co-director of the Penn Sleep Center at Penn Medicine and lead author of the study, told CNN. 3 Visceral fat build up typically targets the back of the tongue, Li explained. vladimirfloyd – Schwab and his colleagues believe that reducing tongue fat through weight loss could be a promising new way to treat sleep apnea. 'Most clinicians, and even experts in the sleep apnea world, have not typically focused on fat in the tongue for treating sleep apnea,' he said in a statement. Advertisement 'Now that we know tongue fat is a risk factor and that sleep apnea improves when tongue fat is reduced, we have established a unique therapeutic target that we've never had before,' Schwab added. Even if you don't have full-blown sleep apnea, Li says new snoring or snorting during sleep can be an early warning sign of dangerous fat buildup — long before it shows on the scale or in the mirror. Catching it early is crucial, since research suggests that preventing obesity is often easier and more effective than trying to reverse it later. That's a big deal, because America's obesity epidemic is only expected to get worse. Right now, more than 2 in 5 US adults are obese, along with roughly 1 in 5 kids and teens, according to the Centers for Disease Control and Prevention.
Bloomberg
28 minutes ago
- Bloomberg
Gilead Falls as CVS Hasn't Yet Added PrEP HIV Shot to Drug Plans
Gilead Sciences Inc.'s shares fell after CVS Health Corp said it hasn't yet added its new HIV prevention shot to its commercial drug plans. 'As is typical with new-to-market products, we undergo a careful review of clinical, financial, and regulatory considerations,' CVS spokesperson David Whitrap said in a statement. At this time, Gilead's drug hasn't been added to CVS Caremark 's commercial drug plans or Affordable Care Act plans, Whitrap said.
Politico
an hour ago
- Politico
Lawmakers offload UnitedHealth stock
With help from Carmen Paun PROGRAMMING NOTE: Pulse will be on hiatus from Aug. 25 through Sept. 1. We'll be back to our normal schedule on Tuesday, Sept. 2. Driving the Day STOCK ACTIVITY — Some Washington policymakers with financial stakes in UnitedHealth Group are selling their stocks in the company as it struggles financially and the Trump administration investigates its billing practices, Kelly reports. Lawmakers of both parties have sold off UnitedHealth stock worth as much as $1.2 million, against $950,000 in purchases this year, according to a POLITICO review of stock trading. An uptick in sales in recent months comes as Congress and the Trump administration probe the health care behemoth over billing practices and how often it denies care. Why it matters: Congress members' stock sales are legal even though some of them sit on committees that oversee the insurance industry. The sales come amid an effort in Congress to ban members from trading stocks to prevent conflicts of interest — which some lawmakers have said they support and cite as justification for their decisions to sell. Dan Weiskopf, an investment portfolio manager at Tidal Financial Group who tracks congressional stock trading, said if he were an investor in the insurer, he'd 'be very concerned when I saw that the regulators, as members of Congress, are dumping the stock. That's very clearly a red flag.' Background: Bipartisan lawmakers in Congress have signaled interest in cracking down on overpayments to the privately run Medicare Advantage program, in which UnitedHealth Group has a large stake, and probing excessive care-denial claims. Additionally, the Department of Justice is investigating the company's Medicare billing practices. The Wall Street Journal first reported a civil DOJ investigation in February, and in the week following, Democratic California Reps. Ro Khanna and Gil Cisneros and Republican Indiana Rep. Jefferson Shreve collectively sold up to $150,000 in UnitedHealth Group stock. All of Khanna's UnitedHealth stock is in trusts belonging to his children and spouse. A spokesperson for Shreve said the representative has not traded personally-held stocks as a member of Congress, and that he recently directed the assets manager of his charitable trust to divest from individual stocks. Cisneros' spokesperson said his stock trades are managed by outside financial advisers. 'I don't trade any stocks and have pushed for a ban on stock trading, leading the effort to pass the TRUST in Congress Act,' said Khanna, a member of the Oversight and Accountability Committee, the House's main investigative arm, in a statement. That bill would require members of Congress to place their assets in blind trusts. Rep. David Taylor (R-Ohio) sold up to $65,000 in company shares on the same day in May that The Wall Street Journal reported the DOJ had launched a criminal probe into the company's Medicare billing practices. The next day, Rep. Jared Moskowitz (D-Fla.) sold shares worth up to $45,000 — some of it owned by his children. Rep. Robert Bresnahan (R-Pa.) sold stock worth as much as $50,000. Taylor, Moskowitz and Bresnahan did not respond to requests for comment. Even so: Some lawmakers who sold their UnitedHealth Group stocks this year said they are divesting all of their shares in support of the congressional push to remove conflicts of interest. That includes freshman Rep. Julie Johnson (D-Texas) and Rep. Greg Landsman (D-Ohio), according to their spokespeople. Johnson sold UnitedHealth stock worth up to $30,000 between April and July, and Landsman reported selling stock — owned by his spouse — worth up to $50,000 in March. WELCOME TO THURSDAY PULSE. High levels of exposure to technology can be cognitively harmful to children and teens, data has shown, but researchers are finding that the opposite is true for older adults. Send your tips, scoops and feedback to khooper@ and sgardner@ and follow along @kelhoops and @sophie_gardnerj. At the Agencies HUNDREDS OF CDC WORKERS LET GO — About 600 CDC employees are receiving permanent termination notices after a court ruling last week paved the way for the agency to move forward with some firings, according to the union representing agency workers. The cuts are across the Division of Violence Prevention, Office of Equal Employment Opportunity, the Freedom of Information Act office, the Office of Financial Resources and the offices of the chief information and chief operating officers, said a spokesperson for the American Federation of Government Employees, which represents more than 2,000 dues-paying members at the CDC. HHS referred POLITICO to a March announcement on agency restructuring. Background: A U.S. district court judge agreed last week to narrow an injunction that had been blocking the Trump administration's plan to fire hundreds of CDC employees. The injunction had initially blocked HHS from terminating any CDC employees, but the revised order blocks only six of the agency's centers from the reduction in force. The centers still blocked from terminations include the CDC's National Center for HIV, Viral Hepatitis, STD and Tuberculosis Prevention; the Division of Reproductive Health; the National Institute for Occupational Safety and Health; the Office on Smoking and Health; the National Center for Environmental Health; and the National Center on Birth Defects and Developmental Disabilities. Key context: The terminations come as CDC employees are dealing with the impact of a shooting earlier this month that targeted the agency's headquarters in Atlanta. Eye on Insurers EMPLOYERS WORRY ABOUT COSTS — Most small and mid-sized businesses offering their workers group health insurance are concerned they won't be able to afford the benefit within three years, according to a new survey from health insurance marketplace eHealth. The findings come as employer health costs are projected to jump 9 percent next year, the highest increase since at least 2017, according to a Business Group on Health survey published earlier this week. The spike comes as more Americans seek out medical care and are prescribed costly medications, like weight-loss drugs. Most Americans under 65 — more than 160 million people — are enrolled in health insurance through their employers. eHealth's findings: Nearly 90 percent of the businesses surveyed said they're concerned health benefits will be too costly to provide to employees within three years. Three-quarters of the respondents said they'd be in favor of switching to a health benefits model called an Individual Coverage Health Reimbursement Arrangement, or ICHRA, which allows employers to offer their workers a tax credit to purchase health insurance on the Affordable Care Act exchange in lieu of a group plan. But more than half of the respondents said they're unfamiliar or uneducated on the policy. Background: The arrangements — a Trump first-term policy — have gained some traction recently, as employers grapple with the high costs and administrative burden that come with offering traditional group plans. But changes to the ACA enacted in the Republicans' megabill, the expiration of enhanced federal Obamacare subsidies at year's end and a new Trump administration marketplace rule could lead to fewer young and healthy people enrolled in the ACA market and higher premiums — making offering ICHRAs less attractive for employers, policy experts recently told POLITICO. Key context: The national survey was conducted in July among 503 owners and managers of small to mid-sized businesses — those with 500 employees or fewer. Global Health NOT OUT OF THE MEASLES WOODS — The Texas measles outbreak might be over, but the U.S. measles-free status is still at risk, according to the Pan-American Health Organization, the regional arm of the World Health Organization, Carmen reports. Other states have reported cases linked to the Texas outbreak, a PAHO spokesperson said, pointing to New Mexico as an example. The Idaho health department reported a third confirmed measles case Wednesday, in an unvaccinated child. 'To maintain measles elimination status, a country must have controlled and ended all outbreaks related to the first case identified (in this case, in Texas) within twelve months,' the PAHO spokesperson said via email. Names in the News Accountable for Health, an advocacy organization committed to accelerating the adoption of effective value-based care, is adding Patrick McConnell as director of federal affairs. McConnell, an alumnus of former Rep. Max Rose (D-N.Y.), previously was director at Rational 360 and graduated from Hamilton College. WHAT WE'RE READING POLITICO's Tyler Katzenberger reports on California policy influencers supporting harsher social media laws than the state's voters. KFF Health News' Fred Clasen-Kelly and Renuka Rayasam report on the toll of the nation's gun violence epidemic.
